NZ546059A

NZ546059A - Inhaler including flow sensor and feedback mechanism

Info

Publication number: NZ546059A
Application number: NZ546059A
Authority: NZ
Inventors: Andrew L Abrams; Anand V Gumaste
Original assignee: Microdose Technologies Inc
Priority date: 2001-09-06
Filing date: 2002-09-06
Publication date: 2007-07-27

Abstract

An inhaler for delivering medication to the respiratory tract comprising a flow sensor (14) for sensing the rate of inhalation and a feedback mechanism to transmit this information to the patient.

Description

<div class="application article clearfix" id="description"> 5 46059 10050861330^ NEW ZEALAND PATENTS ACT, 1953 Divided out ofNZ 531614 Dated 6 September 2002 COMPLETE SPECIFICATION ADAPTORS FOR INHALERS TO IMPROVE PERFORMANCE We, MICRODOSE TECHNOLGIES, INC., of 4262 U.S. Route 1, Suite 3, Monmouth Junction, New Jersey 08852, United States of America, do hereby declare the invention for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement: 583892-1 1 INTELLECTUAL PROPERTY OFFICE Or N.Z. 2 2 (HAS 2G05 RE WO 03/022332 PCT/US02/30308 1 This application is a divisional of NZ 531614. 2 3 The present invention relates generally to the field of inhalation devices, and more 4 specifically, to a mouthpiece adaptor and patient feedback for an inhaler. The invention 5 has particular utility as a mouthpiece adaptor and patient feedback for inhalation devices 6 such as dry powder inhalers ("DPls") for facilitating use of same by pediatric, geriatric 7 and compromised patients, and will be described in connection with such utility, although 8 other utilities are contemplated such as for use with metered dose inhalers ("MDIs") and 9 nebulizers. 10 Metered dose inhalers (MDIs) depend on delivery technique to deliver the proper 11 amount of medication to the lungs. A properly delivered MDI medication depends on 12 dexterity, coordination, timing, and practice. This can be a real problem when the patient 13 is young, has coordination problems, or especially irritable airways. 14 An alternative to MDIs are dry powder inhaler devices (DPIs), which are 15 activated by the patient's inspiratory effort, so that coordination is not a problem, 16 although inhalation technique is still important. The drug is aerosolized by the airflow 17 through a DPI created by the patient inhaling. DPI devices are easy to use and are thus 18 suitable for most ages. Newer multidose types of powder devices have electronics which 19 include dose counters, which enable patients to check whether or not they have taken a 20 dose and warns them when the inhaler is running out of doses by showing them exactly 21 how many doses remain. U.S. Patent 6,142,146 to Abrams et al. discloses this type of 22 device. However, dry powder inhalers require patients to inspire reasonably rapidly to 23 inhale the dry powder, so these devices are not suitable for younger children and infants. 24 Further, even if young children and infants could conform to the protocol for using the 25 device, current devices have mouthpieces which are too cumbersome for these patients. 26 When dealing with bronchial diseases among children and infants, it is difficult to 27 make the patient properly inhale the therapeutic substances necessary for treatment. 28 When asthma makes its debut among infants and young children, typically at 8 months to 29 2.5 years, it is especially difficult to make a child or infant inhale the prescribed medical 1 WO 03/022332 PCT/US02/30308 1 substances in the proper way. Children and infants have limited lung capacity and the 2 force of a child's or infant's breath during inhalation (inhalation flow) is thus limited. 3 This is even more apparent when the child or infant is suffering from asthma or other 4 bronchial diseases. Parents also desire that the devices used for inhalation be as flexible 5 as possible, as it is difficult to position the inhaler in a way that will allow proper 6 inhalation by an infant. 7 For patients of limited or compromised inhalation capacity, inhalation therapy 8 may be accomplished through the use of inhalation chambers. An inhalation chamber 9 typically includes an inlet and fixture for a medicament dispenser, e.g., an MDI, and an 10 expanded hollow body, which in the technical field of inhalers normally is called a 11 "spacer" or inhalation chamber, having an outlet provided at the end remote from the 12 inlet. An inhalation/exhalation valve, e.g., a one-way valve, typically is provided 13 adjacent the outlet, and a mouthpiece is provided at the outlet. When such a device is 14 used by older children or adults the mouthpiece is inserted between the teeth and the lips 15 are closed around the mouthpiece. It is, however, not possible for young children and 16 infants to hold such a mouthpiece between their lips. Moreover, these devices are 17 constructed to be used by older children who have large lung capacity and who can inhale 18 more forcefully. The inhalation/exhalation valves provided typically require a certain 19 inhalation flow, which a child or infant is unable to generate, to open properly. 20 Therefore, for satisfactory inhalation to be achieved by young children and infants, 21 inhalation devices often are provided with a face mask. 22 However, some small children and infants find standard inhalation devices 23 employing masks frightening, and, as a consequence, resist using them. Faced with 24 strong resistance from children, many care-givers responsible for administering 25 medication to children report a reluctance to offer air-borne drugs for use with standard 26 inhalation devices employing masks on a regular basis. In addition, care-givers also 27 report that even when attempted, the delivery of aerosol/gas medication to children is 28 often sub-optimal because the child cries and/or forcibly removes the mask from their 29 face before the medication is taken properly. Many patients who cannot use MDIs or DPIs, even with inhalation chambers, are forced to use nebulizers. Nebulizers produce a cloud of medication by passing a jet of compressed air through a solution of a drug (jet nebulizers) or by dropping the drug solution onto a plate vibrating at high frequency (ultrasonic nebulizers). Nebulizers have the advantage of being able to be used by patients of all ages, including young babies, because coordination is unimportant. However, disadvantages of nebulizers include that they are cumbersome, expensive (both the machine and the drugs) and noisy; require a power source, typically lines (AC) current; treatment takes a long time, often around ten minutes; and young patients are required to wear a mask. The amount of drug delivered to the lungs is highly dependant on the breathing pattern of the patient. All these factors tie down the patient and care-giver. Because nebulizers have the above problems, several devices have been developed in order to entice or teach children how to use MDIs or DPIs, so that a nebulizer is unnecessary. But, those devices designed for use by young children require a mask adaptor for the MDI or DPI. PCT Application No. 995398 to Watt and European Patent 667168 to Minar et al. disclose incentive systems of this type. Quite apart from the foregoing, conventional MDIs and DPIs (and also inhalation chambers therefor) have mouthpieces sized for the adult population. Thus, conventional MDIs, DPIs and inhalation chambers therefor have mouthpieces that are too big to be comfortably used by small children and infants. Moreover, the mouthpieces of conventional MDIs, DPIs and spacers are primarily rectangular in shape, which is somewhat awkward, or at least unfamiliar, particularly to small children. SUMMARY OF THE INVENTION* ;This invention seeks to solve the problems with the prior art by allowing young children, geriatric and compromised patients to use DPIs, MDIs and inhalation chambers mask-free. Another aspect of the invention seeks to solve the issue of consistent patient inhalation in the pediatric, geriatric or physically challenged patients. Another aspect of the invention seeks to solve the problem of patient compliance when the patient is young, thereby enabling them to use certain devices previously unavailable to them. Yet another aspect of the invention seeks to allow sick or infirm patients to receive a dosage of ;* The objects/advantages stated in the "Summary of the Invention" are of at least preferred embodiments only. It is not necessary for every embodiment to meet all objects/advantages of the invention. 477696-1 3 medicine through an extension to the mouthpiece, thereby allowing the patient to recline while receiving medicine through an inhaler. In one aspect the invention as claimed in parent application NZ 531614 broadly consists in a mouthpiece adaptor for a dry powder or metered dose inhaler comprising: a connecting side for direct connection to a mouthpiece of an inhaler; a mouthpiece side of reduced size relative to the inhaler mouthpiece; and a transition section between said connecting side and mouthpiece side. In another aspect, the invention as claimed herein broadly consists in an inhaler for delivering medication to the respiratory tract comprising a flow sensor for sensing the rate of inhalation and a feedback mechanism to transmit this information to the patient. Still other features and advantages of the present invention may be seen from the following detailed description taken in connection with the attached drawings wherein like numerals depict like parts, and wherein: Figure 1 is a longitudinal view of an exemplary adaptor for an inhaler attached to an inhaler according to one embodiment of the invention; Figure 2 is a longitudinal view of an exemplary adaptor for an inhaler attached to an inhaler according to another embodiment of the invention; Figure 3 is a longitudinal view of an exemplary adaptor for an inhaler attached to an inhaler according to yet another embodiment of the invention; Figure 4 is a frontal view of an exemplaiy adaptor for an inhaler and a mouthpiece for an adaptor according to one embodiment of the invention; Figure 5 is a frontal view of an exemplary adaptor for an inhaler and the mouthpiece of the adaptor according to another embodiment of the invention; Figure 6 is a longitudinal view of an exemplary adaptor for an inhaler attached to the inhaler according to yet another embodiment of the invention; Figure 7 is a functional block diagram of the sensor-light/sound mechanism of the invention according to one embodiment of the invention; Figure 8 is a longitudinal view of an exemplary adaptor employing the sensor-light/sound mechanism of Figure 7; and 583840-1 4 (followed by page 4a) INTELLECTUAL PROPERTY OFFICE OF N.Z. 21 SEP 2006 RECEIVED Figure 9 is a frontal view of an exemplary adaptor with a sensor-light/sound mechanism according to the embodiment shown in Figure 8. The detailed description of the preferred embodiments illustrates the use of the adaptor with MDIs and DPIs. However, each of the described embodiments of the adaptor also can be used in conjunction with spacer devices and nebulizers. 583840-1 INTELLECTUAL PROPERTY OFFICE OF N.Z. 2 1 SEP 2006 FfEUETVED (followed by page 5) WO 03/022332 PCT/US02/30308 1 airtight seal. In this embodiment, the adaptor side is designed to create a friction fit with 2 the inhaler mouthpiece. The friction fit is accomplished by creating the attachment side 3 of the adaptor to be just slightly larger in inside dimension than the outside dimension of 4 the inhaler mouthpiece to which it is designed to attach, and sliding the adaptor onto the 5 inhaler mouthpiece, thereby creating an airtight seal. 6 The adaptor 1 also includes a transition section 4 between a mouthpiece side 3 7 and an attachment side 2. The transition section 4 tapers the attachment side 2 of the 8 adaptor to a child-sized mouthpiece side. Aerated particles enter and immediately pass 9 through the connection means from the inhaler mouthpiece upon proper stimulation of 10 the inhalation device. The connecting means does not act as a holding chamber. Here, 11 the connection means is tapered in a funnel-like shape to minimize turbulence and 12 prevent the coagulation of the aerated particles upon usage of the adaptor, which helps 13 maintain the inhaler's effectiveness. 14 The mouthpiece side 3 is child-sized, similar in cross-sectional dimension to that 15 of a drinking straw, i.e., having a diameter in the range of 1mm to 15mm, and is either 16 round or oval shaped, as shown in Figure 4. A round shape for the mouthpiece side is 17 preferred for young children who are already familiar with this shape, i.e., from the use of 18 drinking straws. That is to say, young children are already familiar with using a straw, 19 and have shown that they are capable of proper inspirator pressures. Thus, the 20 mouthpiece side straw-like size and shape not only encourages patient compliance, but 21 also presents a familiar, less frightening alternative to a mask. 22 A second embodiment of mouthpiece adaptor 4 is illustrated in Figure 2. This 23 embodiment, like the first, includes a connecting side 21, a transition section 6, and a 24 mouthpiece side 3. As in the first embodiment, the connecting side 21 must facilitate the 25 formation of an airtight seal. As shown in Figure 2, this is accomplished by securing a 26 plastic or metal clamp 20, which is located on the connecting side 21 of the mouthpiece 27 adaptor. Here, the mouthpiece adaptor attachment side 21 is larger in inside dimension 28 than the outside dimension of the inhaler mouthpiece 10, and allows the adaptor to easily 29 slide on the inhaler mouthpiece 10. Once the mouthpiece adaptor 21 is slid over the WO 03/022332 PCT/US02/30308 1 mouthpiece of the inhaler 10, the clamps 20 are fastened, creating the requisite airtight 2 seal. 3 The mouthpiece adaptor of Figure 2 includes a funnel-like region between the 4 connecting side 21 and the mouthpiece side 3 comprising a slanted wall 7 formed 5 opposite of the inhaler mouthpiece. A metal foil 6 is applied to the slanted wall 6 connected to the circuit of the MDI or DPI and charged by the power source of the MDI 7 or DPI, to the same charge as the particles. This causes a repulsion between the slanted 8 wall and the particles whereby to prevent the particles from collecting on or colliding 9 with the wall, and thus prevent coagulation of the particles on the interior adaptor walls. 10 Further, as with the adaptor of Figure 1, aerated particles only enter and pass through the 11 adaptor of Figure 2 upon proper stimulation of the inhalation device, i.e., the connection 12 means does not act as a holding chamber. 13 The mouthpiece side of the adaptor of Figure 2, as illustrated in Figure 5, is 14 manufactured as a replication of the inhaler mouthpiece. Like the mouthpiece side in the 15 adaptor of Figure 1, the mouthpiece side in the adaptor of Figure 2 is child-sized, i.e., 2 2 16 having cross-sectional dimensional area from 1mm to 200mm. This design, like the 17 round or cylindrical mouthpiece side, also has advantages. Because the shape of the 18 mouthpiece side here is the shape of the inhaler mouthpiece, airflow is concentrated with 19 minimum turbulence. 20 A third embodiment of the instant invention is shown in Figure 3. The third 21 embodiment, like the first and second, includes a connecting side 2, a transition section 4, 22 and a mouthpiece side 3. Here, the connecting side 2 is fitted to the inhaler mouthpiece 23 10 using an attachment means that employs a rubber ring to create an airtight seal. The 24 connecting side 2 is slightly larger than the inhaler mouthpiece 10, and includes on the 25 distal end a taut rubber ring 25 fitted over the connecting side 2. The connecting side 2 is 26 slid over the mouthpiece 10, and the rubber ring is pushed from the top of adaptor 27 connecting side 2 over the mouthpiece of the inhaler 10. In addition, the interior of the 28 attachment side, in which the attachment side of an interior cone 9 is located, and the 6 WO 03/022332 PCT/US02/30308 1 inhaler mouthpiece, link end to end, forming a seal. Thus, there is no ridge on which 2 particles can coalesce, formed between the adaptor and the inhaler mouthpiece 10. 3 Further, in Figure 3 a conical wall 8 is formed on the inside of the transition 4 section 4. The interior wall forms a smooth transition between the inhaler mouthpiece 5 and the adaptor, thereby allowing the particles to move through the inhaler mouthpiece 6 with minimum turbulence. As in the above embodiments, aerated particles only enter 7 and pass through the adaptor when the inhaler is stimulated to pass medication. Thus, the 8 adaptor does not act to hold-up flow of medication. 9 The mouthpiece side in the adaptor of Figure 3 could be shaped, e.g., according to 10 the first or second embodiment. 11 A fourth embodiment of the instant invention is shown in Figure 6. As in the 12 other embodiments, the fourth embodiment consists of a connecting side 2, a transition 13 section 4, and a mouthpiece side 3. However, in the Figure 6 embodiment, the transition 14 section 4 comprises an elongate, curved, generally tubular section of constantly 15 narrowing cross-section. The cross-sectional shape of the transition section 4 preferably 16 is of airfoil shape, so as to minimize turbulence whereby to keep the aerated particles 17 from colliding and coagulating. Further, the extension should be long enough to allow a 18 care-giver to administer medicine from the inhaler to a person lying in a prone or semi- 19 prone position, i.e., without the patient having to sit up or hold the inhaler. Finally, as in 20 the other embodiments, the connecting means facilitates the immediate passage or 21 medication between the inhaler mouthpiece and the oral contact means of the adaptor, 22 without acting as a holding chamber for the medication. 23 In yet another embodiment of the present invention, illustrated in Figures 7-9, the 24 mouthpiece adaptor or the MDI or DPI itself includes electronic means to teach the 25 patient to retrieve a proper breathing pattern. Such electronic means includes a sensor 14, 26 an on/off switch 15, a power source 16, actuation controller 17, noise or light generating 27 means 18, a light 12, and optionally a speaker 13. As shown in Figure 7, the actuation 28 controller 17 supplies power to the noise and light generating means 18 only when the 29 sensor 14 detects a patient is inhaling and the power switch 15 is on. Upon receiving 7 WO 03/022332 PCT/US02/30308 1 power, the noise or light generating means 18 determines the strength and frequency of 2 the inhalations, and generates light and sound based upon these values. If the patient is 3 not attaining the proper breathing pattern for a particular device, the noise and light 4 generating means 18 causes a light 12 to turn red, which signals to the patient to change 5 his or her breathing pattern to conform to the protocols of the device. Correlating sounds 6 may also be produced by the light/sound generating means 18 and output to the speaker 7 13. Once the proper breathing pattern is attained, the light 12 on the adaptor 1 changes 8 from red to green, and/or the sound/light generating means 18 informs the patient that 9 they have attained the proper breathing pattern. 10 In yet another embodiment of the present invention the electronic means to teach 11 the patient to inhale properly is integral to the inhaler. 12 It will be appreciated that although the foregoing detailed description proceeded 13 with reference being made to the preferred embodiments and methods of use, the present 14 invention is not intended to be limited to these preferred embodiments and methods of 15 use. Rather, the invention is of a broad scope and intended to be limited only as set forth 16 in the accompanying claims. The term "comprising" as used in this specification and claims means "consisting at least in part of'. That is to say, when interpreting statements in this specification and claims that include "comprising" the features prefaced by that term all need to be present, but other features can also be present. Related terms such as "comprise" and "comprised" are to be interpreted in a similar manner. INTELLECTUAL PROPERTY OFFICE OF N.Z. 21 SEP 2006 RECEIVED </div>

Claims

<div class="application article clearfix printTableText" id="claims"> WHAT WE CLAIM IS:

1. An inhaler for delivering medication to the respiratory tract comprising a flow sensor for sensing the rate of inhalation and a feedback mechanism to transmit this information to the patient.

2. The inhaler of claim 1, wherein the patient feedback mechanism is acoustic, visual or light in nature.

3. The inhaler of claim 1 or 2, wherein the patient feedback mechanism includes a noise generator operatively connected to said flow sensor.

4. The inhaler of claim 1 or 2, wherein the patient feedback mechanism includes one or more lights operatively connected to said flow sensor.

5. The inhaler of claim 1, wherein said inhaler is a dry powder inhaler.

6. The inhaler of claim 1, wherein said inhaler is a metered dose inhaler.

7. The inhaler for delivering medication to the respiratory tract, substantially as herein described with reference to any one of Figures 7, 8, or 9 of the drawings. intellectual PROPERTY office Oh 2O V108 583840-1 9 </div>